Navigation Links
Cardiomyopathy (Heart Muscle Disease) Therapeutics Clinical Trials Market 2014 Analysis in a New Report Available at MarketOptimizer.org
Date:8/23/2014

Dallas, Texas (PRWEB) August 23, 2014

Cardiomyopathy (heart muscle disease) is the measurable deterioration of the function of the myocardium (the heart muscle) for any reason, usually leading to heart failure; common symptoms are dyspnea (breathlessness) and peripheral edema (swelling of the legs). People with cardiomyopathy are often at risk of dangerous forms of irregular heart beat and sudden cardiac death. The most common form of cardiomyopathy is dilated cardiomyopathy.

Clinical trial report, “Cardiomyopathy Global Clinical Trials Review, H2, 2014? provides data on the Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cardiomyopathy.

Complete report details at http://www.marketoptimizer.org/cardiomyopathy-global-clinical-trials-review-h2-2014.html .

Scope

  •     Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  •     Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  •     Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  •     Understand the dynamics of a particular indication in a condensed manner
  •     Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  •     Obtain discontinued trial listing for trials across the globe
  •     Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Order a purchase copy at http://www.marketoptimizer.org/contacts/purchase?rname=9647 .
(This is a premium report priced at US$2500 for a single user License and US $7500 for Corporate User License)

Major Table of Contents for This Report

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Cardiomyopathy
Report Guidance

Clinical Trials by Region
Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Cardiomyopathy to Cardiovascular Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Cardiomyopathy to Cardiovascular Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase

In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Cardiomyopathy
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors

Top Companies Participating in Cardiomyopathy Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Les Laboratoires Servier SAS
Clinical Trial Overview of Les Laboratoires Servier SAS
Celladon Corporation
Clinical Trial Overview of Celladon Corporation
Aastrom Biosciences, Inc.
Clinical Trial Overview of Aastrom Biosciences, Inc.
Bayer AG
Clinical Trial Overview of Bayer AG
Array BioPharma Inc.
Clinical Trial Overview of Array BioPharma Inc.
AAVLife
Clinical Trial Overview of AAVLife
A. Menarini Industrie Farmaceutiche Riunite Srl
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl
Clinical Trial Overview of Top Institutes / Government
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
Assistance Publique – Hopitaux de Paris
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris
University of Michigan
Clinical Trial Overview of University of Michigan
Osaka University
Clinical Trial Overview of Osaka University
Maastricht University Medical Center
Clinical Trial Overview of Maastricht University Medical Center
University Health Network
Clinical Trial Overview of University Health Network
Johann Wolfgang Goethe University Hospitals
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
Stanford University
Clinical Trial Overview of Stanford University
Five Key Clinical Profiles

Explore more reports on Pharmaceuticals industry at http://www.marketoptimizer.org/category/energy-power/energy.

About Us:
MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/cardiomyopathy-clinical/trials-review-h2-2014/prweb12116856.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Beware: Newly recognized heart cardiomyopathy is not always benign
2. Biomarker test for Peripartum Cardiomyopathy could help reduce death after giving birth
3. Ronald S. Weaver, MD, Owner of Global Cardio Care Centers, Announces EECP Treatment Success for Cardiomyopathy Patient Who Needed Heart Transplant
4. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
5. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
6. Mayo Clinic study links healthy muscle mass to healthy bones, finds differences by gender
7. Experimental drug improves muscle strength among male cancer patients
8. Muscle Mass Linked to Bone Health in Some Parts of Body
9. Heuer M.D. Research Announces CardiaShred™ - First Medical Doctor Formulated, Heart Healthy Weight Loss, Energy and Lean Muscle Building Supplement
10. Strong communication between brain and muscle requires both having the protein LRP4
11. Lab-engineered muscle implants restore function in animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017 ... , and OptiMed Specialty Pharmacy of Kalamazoo, ... offer a strategic hub service that expedites and streamlines ... personal spirometer, Spiro PD 2.0, and wellness management services.  ... is a medical device used to measure lung function ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , the ... chains, has published the first annual edition of its Global CSR Risk ... 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly ... ... Performance Index ...
(Date:9/9/2017)... , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September ... Washington, D.C. offering free MRI brain scans to the public.Where:  ... will be parked at 501 K Street NW, Washington, D.C.What:BTF brings its ...
Breaking Medicine Technology: